Furthermore, we have investigated for the first time 11C-MET PET volume-based biomarkers (TMTV, TMLU) demonstrating a positive correlation with MM serum markers of tumor burden such as M component, bone marrow (BM) infiltration, or B2M. This evidence concerns the gene B2M and Miyoshi myopathy.